151 related articles for article (PubMed ID: 16271960)
1. Poor clinical course in a child with myelodysplastic syndrome and del(13)(q14q22).
Oren H; Yüksel E; Yilmaz S; Türker M; Demircioğlu F; Irken G
Cancer Genet Cytogenet; 2005 Nov; 163(1):74-6. PubMed ID: 16271960
[TBL] [Abstract][Full Text] [Related]
2. A novel recurrent chromosomal aberration involving chromosome 7 in childhood myelodysplastic syndrome.
Lizcova L; Zemanova Z; Malinova E; Jarosova M; Mejstrikova E; Smisek P; Pospisilova D; Stary J; Michalova K
Cancer Genet Cytogenet; 2010 Aug; 201(1):52-6. PubMed ID: 20633770
[TBL] [Abstract][Full Text] [Related]
3. Concomitant isochromosome 17q and trisomy 14 in a patient with myelodysplastic syndrome in leukemic transformation.
Park TS; Song J; Lee JH; Kim JS; Yang WI; Choi JR
Ann Clin Lab Sci; 2009; 39(2):176-81. PubMed ID: 19429805
[TBL] [Abstract][Full Text] [Related]
4. Gain of 1q in pediatric myelodysplastic syndromes.
Morerio C; Rapella A; Tassano E; Lanino E; Micalizzi C; Rosanda C; Panarello C
Leuk Res; 2006 Nov; 30(11):1437-41. PubMed ID: 16472857
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndromes with isolated deletion of the long arm of the chromosome X as a sole cytogenetic change.
Olshanskaya YV; Udovichenko AI; Vodinskaya LA; Glasko EN; Parovitchnikova EN; Lorie YY; Dvirnik VN; Savchenko VG; Domracheva EV
Cancer Genet Cytogenet; 2006 May; 167(1):47-50. PubMed ID: 16682286
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study.
Aktas D; Tuncbilek E
Cancer Genet Cytogenet; 2006 Nov; 171(1):72-5. PubMed ID: 17074595
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.
Haferlach C; Bacher U; Tiu R; Maciejewski JP; List A
Cancer Genet Cytogenet; 2008 Dec; 187(2):101-11. PubMed ID: 19027491
[TBL] [Abstract][Full Text] [Related]
9. [Detection of cytogenetic abnormalities involving chromosomes 5,7 and 8 in myelodysplastic syndromes with fluorescence in situ hybridization and its clinical significance].
Cai Y; Qin YW; Wang C; Yang J; Yan SK
Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):6-10. PubMed ID: 17649717
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes.
Olney HJ; Le Beau MM
Leuk Res; 2007 Apr; 31(4):427-34. PubMed ID: 17161457
[TBL] [Abstract][Full Text] [Related]
11. Deletion (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review.
Panani AD; Pappa V; Papageorgiou S; Stamatelli F; Raptis SA
Ann Hematol; 2004 Mar; 83(3):153-5. PubMed ID: 15064863
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
Panani AD; Roussos C
Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
[TBL] [Abstract][Full Text] [Related]
13. Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report.
Znoyko I; Stuart RK; Ellingham T; Winters J; Wolff DJ; Quigley DI
Cancer Genet Cytogenet; 2008 May; 183(1):64-8. PubMed ID: 18474300
[TBL] [Abstract][Full Text] [Related]
14. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
Slovak ML; O'Donnell M; Smith DD; Gaal K
Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
[TBL] [Abstract][Full Text] [Related]
15. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
Nimer SD
J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic findings in adult greek myelodysplastic syndrome patients: predominance of single trisomy 8.
Panani AD
In Vivo; 2006; 20(1):115-8. PubMed ID: 16433038
[TBL] [Abstract][Full Text] [Related]
17. Role of chromosome 1 pericentric heterochromatin (1q) in pathogenesis of myelodysplastic syndromes: report of 2 new cases.
Millington K; Hudnall SD; Northup J; Panova N; Velagaleti G
Exp Mol Pathol; 2008 Apr; 84(2):189-93. PubMed ID: 18339374
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
19. Therapy-related myelodysplastic syndrome in childhood: a retrospective study of 36 patients in Japan.
Tsurusawa M; Manabe A; Hayashi Y; Akiyama Y; Kigasawa H; Inada H; Noguchi Y; Sawai N; Kobayashi R; Nagatoshi Y; Kawakami K; Kojima S; Nakahata T;
Leuk Res; 2005 Jun; 29(6):625-32. PubMed ID: 15863201
[TBL] [Abstract][Full Text] [Related]
20. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
